Literature DB >> 18854419

Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.

Atsuko Kamijo-Ikemori1, Takeshi Sugaya, Ayako Sekizuka, Kazuaki Hirata, Kenjiro Kimura.   

Abstract

BACKGROUND: Renoprotection of liver-type fatty acid binding protein (L-FABP) was demonstrated in a streptozotocin (STZ)-induced diabetic mouse model.
METHODS: Established human L-FABP (hL-FABP) transgenic (Tg) mice and wild-type (WT) mice were divided into two groups: diabetic mice were uninephrectomized and injected with STZ; control mice were uninephrectomized and injected with a citrate buffer alone. Although mouse L-FABP was not expressed in WT mice, hL-FABP was expressed in the proximal tubules of the diabetic Tg mice and in the control Tg mice at 8 and 14 weeks after these injections.
RESULTS: The expression of renal hL-FABP increased significantly in diabetic Tg mice compared to control Tg mice. A number of macrophages (F4/80) infiltrating the interstitium, the gene expressions of MCP-1, MCP-3, TGF-beta, Fas, Bax and RAGE were significantly lower in diabetic Tg kidneys compared with diabetic WT kidneys. In the diabetic Tg kidneys, the degree of the tubulointerstitial injury and the deposition of type IV collagen were significantly lower than that of diabetic WT kidneys. The expressions of catalase and glutathione peroxidase-1 were significantly lower in diabetic Tg kidneys compared with diabetic WT kidneys.
CONCLUSIONS: Renal L-FABP ameliorated the tubulointerstitial damage of type 1 diabetic mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854419     DOI: 10.1093/ndt/gfn573

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  20 in total

1.  Fatty acid induced remodeling within the human liver fatty acid-binding protein.

Authors:  Ashwani Sharma; Amit Sharma
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

2.  Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals.

Authors:  Keisei Kosaki; Atsuko Kamijo-Ikemori; Takeshi Sugaya; Koichiro Tanahashi; Hiroshi Kumagai; Yuriko Sawano; Nobuhiko Akazawa; Song-Gyu Ra; Kenjiro Kimura; Yugo Shibagaki; Seiji Maeda
Journal:  Clin Exp Nephrol       Date:  2017-02-14       Impact factor: 2.801

3.  Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α.

Authors:  Heather A Hostetler; Madhumitha Balanarasimha; Huan Huang; Matthew S Kelzer; Alagammai Kaliappan; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2010-07-13       Impact factor: 5.922

Review 4.  Novel urinary biomarkers in early diabetic kidney disease.

Authors:  Atsuko Kamijo-Ikemori; Takeshi Sugaya; Kenjiro Kimura
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

5.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Clinical significance of tubular and podocyte biomarkers in acute kidney injury.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemori; Masanori Hara; Takeshi Sugaya; Takamitsu Kodama; Sigeki Fujitani; Yasuhiko Taira; Takashi Yasuda; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2010-12-14       Impact factor: 2.801

7.  L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.

Authors:  Heather A Hostetler; Avery L McIntosh; Barbara P Atshaves; Stephen M Storey; H Ross Payne; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2009-03-16       Impact factor: 5.922

8.  L-FABP can be an early marker of acute kidney injury in children.

Authors:  Ivana Ivanišević; Amira Peco-Antić; Irena Vuličević; Dorđe Hercog; Vladimir Milovanović; Jelena Kotur-Stevuljević; Aleksandra Stefanović; Nikola Kocev
Journal:  Pediatr Nephrol       Date:  2013-02-14       Impact factor: 3.714

9.  Hepatic phenotype of liver fatty acid binding protein gene-ablated mice.

Authors:  Gregory G Martin; Barbara P Atshaves; Huan Huang; Avery L McIntosh; Brad J Williams; Pei-Jing Pai; David H Russell; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

10.  Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.

Authors:  Takeshi Yokoyama; Atsuko Kamijo-Ikemori; Takeshi Sugaya; Seiko Hoshino; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.